Øystein Rekdal
Chief Executive Officer chez LYTIX BIOPHARMA
Fortune : 79 132 $ au 31/03/2024
Profil
Øystein Rekdal is the founder of Lytix Biopharma AS, a company founded in 2003.
He holds the title of Chief Executive Officer at Lytix Biopharma AS starting in 2019.
Dr. Rekdal's current job is as a Professor at the University of Tromso.
He previously worked as a Director at Prophylix AS.
Dr. Rekdal obtained a doctorate degree from the University of Tromso.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LYTIX BIOPHARMA AS
0,35% | 26/08/2022 | 139 963 ( 0,35% ) | 79 132 $ | 31/03/2024 |
Postes actifs de Øystein Rekdal
| Sociétés | Poste | Début |
|---|---|---|
| LYTIX BIOPHARMA | Chief Executive Officer | 11/09/2019 |
| University of Tromso | Corporate Officer/Principal | - |
Anciens postes connus de Øystein Rekdal
| Sociétés | Poste | Fin |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Director/Board Member | - |
Formation de Øystein Rekdal
| University of Tromso | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
